ストックスクリーナーアプリを入手
1.17
12.50%
0.13
アフターアワーズ：
1.23
0.06
+5.13%
Alector Inc (ALEC) 最新ニュース
Alector (ALEC) Maintains Buy Rating as Price Target Increases | ALEC Stock News - GuruFocus
Alector (ALEC) Price Target Raised by H.C. Wainwright | ALEC Stock News - GuruFocus
Alector Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Alector (ALEC) Reports Q1 Revenue Shortfall, Advances Drug Trials | ALEC Stock News - GuruFocus
Alector reports Q1 EPS (41c), consensus (46c) - TipRanks
Alector Inc Reports Q1 2025 Earnings: EPS Loss of $0.41 Beats Estimates, Revenue Falls Short at $3.7 Million - GuruFocus
Alector, Inc. SEC 10-Q Report - TradingView
Alector Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Alector Sets Stage for Major Healthcare Conference Appearances: BofA and H.C. Wainwright Presentations Coming Up - Stock Titan
Alector, Inc. (NASDAQ:ALEC) Position Raised by Invesco Ltd. - Defense World
Alector Inc (NASDAQ: ALEC) Analysts Expect It Could Climb 71.8% From Current Levels. - Stocksregister
Alector, Inc. (NASDAQ:ALEC) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Alector Inc (ALEC) shows promising results - uspostnews.com
Alector Inc [ALEC] Shares Fall Approximately -76.81% Over the Year - knoxdaily.com
Market Highlights: Alector Inc (ALEC) Ends on a High Note at 1.22 - DWinneX
Alector Inc (ALEC) Stock: A Comprehensive 52-Week Review - investchronicle.com
XTX Topco Ltd Acquires 22,381 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Geode Capital Management LLC Boosts Stake in Alector, Inc. (NASDAQ:ALEC) - Defense World
Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World
Alector Inc (ALEC): A Sitting Duck With -250.88% Upside Potential - Stocksregister
Following a 75% decline over last year, recent gains may please Alector, Inc. (NASDAQ:ALEC) institutional owners - simplywall.st
There is no way Alector Inc (ALEC) can keep these numbers up - Sete News
A Guide To The Risks Of Investing In Alector Inc (ALEC) - knoxdaily.com
ALEC’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Neogenomics Inc (NEO) Stock’s Detailed Analysis - Marketing Sentinel
Alector Inc (ALEC): What Makes The Stock Good? - Marketing Sentinel
Gentherm Inc Is A Buy Small Cap Stock: Analysts - Marketing Sentinel
Alector, Inc. (NASDAQ:ALEC) Holdings Cut by JPMorgan Chase & Co. - Defense World
Alector concludes enrolment in Phase II trial of Alzheimer’s treatment - Yahoo Finance
What Analysts Were Expecting After Alector Inc (NASDAQ: ALEC) fell -5.95% - Stocksregister
Alector Completes Enrollment for Phase 2 Alzheimer's Trial of AL101 - marketscreener.com
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease - GlobeNewswire
Alector (ALEC) Completes Enrollment for Alzheimer's Drug Trial | - GuruFocus
Major Milestone: Alector's Innovative Alzheimer's Drug Trial Hits Full Enrollment Ahead of Schedule - Stock Titan
Alector stock hits 52-week low at $0.99 amid sharp decline By Investing.com - Investing.com South Africa
Alector stock hits 52-week low at $0.99 amid sharp decline - Investing.com India
Alector, Inc. (NASDAQ:ALEC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com
Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com
Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com
Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter
Alector Announces Resignation of Chief Medical Officer - TipRanks
Alector Appoints New Chief Medical Officer - MarketScreener
Alector Provides Executive Leadership Update - The Manila Times
Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan
Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace
Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st
Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa
Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com
Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha
Mizuho’s latest rating for ALEC stock - Knox Daily
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):